O	0	1	A
O	2	9	cluster
O	9	10	-
O	10	20	randomized
O	21	26	trial
O	27	29	of
O	30	31	a
O	32	39	primary
O	40	44	care
B-intervention	45	56	informatics
I-intervention	56	57	-
I-intervention	57	62	based
I-intervention	63	69	system
O	70	73	for
O	74	80	breast
O	81	87	cancer
O	88	97	screening
O	97	98	.

O	99	110	Information
O	111	121	technology
O	122	128	offers
O	129	132	the
O	133	140	promise
O	140	141	,
O	142	144	as
O	145	148	yet
O	149	160	unfulfilled
O	160	161	,
O	162	164	of
O	165	175	delivering
O	176	185	efficient
O	185	186	,
O	187	195	evidence
O	195	196	-
O	196	201	based
O	202	208	health
O	209	213	care
O	213	214	.

O	215	217	To
O	218	226	evaluate
O	227	234	whether
O	235	236	a
O	237	244	primary
O	245	249	care
O	250	257	network
O	257	258	-
O	258	263	based
O	264	275	informatics
O	276	288	intervention
O	289	292	can
O	293	300	improve
O	301	307	breast
O	308	314	cancer
O	315	324	screening
O	325	330	rates
O	330	331	.

O	332	339	Cluster
O	339	340	-
O	340	350	randomized
O	351	361	controlled
O	362	367	trial
O	368	370	of
O	371	373	12
O	374	381	primary
O	382	386	care
O	387	396	practices
O	397	406	conducted
O	407	411	from
O	412	417	March
O	418	420	20
O	420	421	,
O	422	426	2007
O	427	429	to
O	430	435	March
O	436	438	19
O	438	439	,
O	440	444	2008
O	444	445	.

O	446	451	Women
B-age	452	454	42
I-age	454	455	-
I-age	455	457	69
I-age	458	463	years
O	464	467	old
B-eligibility	468	472	with
I-eligibility	473	475	no
I-eligibility	476	482	record
I-eligibility	483	485	of
I-eligibility	486	487	a
I-eligibility	488	497	mammogram
I-eligibility	498	500	in
I-eligibility	501	504	the
I-eligibility	505	510	prior
I-eligibility	511	512	2
I-eligibility	513	518	years
O	518	519	.

O	520	522	In
O	523	535	intervention
O	536	545	practices
O	545	546	,
O	547	548	a
O	549	559	population
O	559	560	-
O	560	565	based
O	566	577	informatics
O	578	584	system
O	585	588	was
O	589	600	implemented
O	601	605	that
O	605	606	:
O	607	616	connected
O	617	624	overdue
O	625	633	patients
O	634	636	to
O	637	648	appropriate
O	649	653	care
O	654	663	providers
O	663	664	,
O	665	674	presented
O	675	684	providers
O	685	689	with
O	690	691	a
O	692	695	Web
O	695	696	-
O	696	701	based
O	702	706	list
O	707	709	of
O	710	715	their
O	716	723	overdue
O	724	732	patients
O	733	735	in
O	736	737	a
O	738	741	non
O	741	742	-
O	742	747	visit
O	747	748	-
O	748	753	based
O	754	761	setting
O	761	762	,
O	763	766	and
O	767	774	enabled
O	775	776	"
O	776	779	one
O	779	780	-
O	780	785	click
O	785	786	"
O	787	798	mammography
O	799	807	ordering
O	808	810	or
O	811	821	documented
O	822	830	deferral
O	831	838	reasons
O	838	839	.

O	840	848	Patients
O	849	857	selected
O	858	861	for
O	862	873	mammography
O	874	882	received
O	883	896	automatically
O	897	906	generated
O	907	914	letters
O	915	918	and
O	919	925	follow
O	925	926	-
O	926	928	up
O	929	934	phone
O	935	940	calls
O	940	941	.

O	942	945	All
O	946	955	practices
O	956	959	had
O	960	970	electronic
O	971	977	health
O	978	984	record
O	985	994	reminders
O	995	1000	about
O	1001	1007	breast
O	1008	1014	cancer
O	1015	1024	screening
O	1025	1034	available
O	1035	1041	during
O	1042	1050	clinical
O	1051	1061	encounters
O	1061	1062	.

O	1063	1066	The
O	1067	1074	primary
O	1075	1082	outcome
O	1083	1086	was
O	1087	1090	the
B-outcome-Measure	1091	1101	proportion
I-outcome-Measure	1102	1104	of
I-outcome-Measure	1105	1112	overdue
I-outcome-Measure	1113	1118	women
I-outcome-Measure	1119	1129	undergoing
I-outcome-Measure	1130	1141	mammography
I-outcome-Measure	1142	1144	at
I-outcome-Measure	1145	1146	1
I-outcome-Measure	1146	1147	-
I-outcome-Measure	1147	1151	year
I-outcome-Measure	1152	1158	follow
I-outcome-Measure	1158	1159	-
I-outcome-Measure	1159	1161	up
O	1161	1162	.

B-outcome	1163	1171	Baseline
I-outcome	1172	1183	mammography
I-outcome	1184	1189	rates
O	1190	1192	in
O	1193	1205	intervention
O	1206	1209	and
B-control	1210	1217	control
I-control	1218	1227	practices
O	1228	1231	did
O	1232	1235	not
O	1236	1242	differ
O	1243	1244	(
B-iv-bin-percent	1244	1246	79
I-iv-bin-percent	1246	1247	.
I-iv-bin-percent	1247	1248	5
I-iv-bin-percent	1248	1249	%
O	1250	1252	vs
B-cv-bin-percent	1253	1255	79
I-cv-bin-percent	1255	1256	.
I-cv-bin-percent	1256	1257	3
I-cv-bin-percent	1257	1258	%
O	1258	1259	,
O	1260	1261	p
O	1262	1263	=
O	1264	1265	0
O	1265	1266	.
O	1266	1268	73
O	1268	1269	)
O	1269	1270	.

O	1271	1276	Among
B-intervention-participants	1277	1278	3
I-intervention-participants	1278	1279	,
I-intervention-participants	1279	1282	054
O	1283	1288	women
O	1289	1291	in
O	1292	1304	intervention
O	1305	1314	practices
O	1315	1318	and
B-control-participants	1319	1320	3
I-control-participants	1320	1321	,
I-control-participants	1321	1324	676
O	1325	1330	women
O	1331	1333	in
O	1334	1341	control
O	1342	1351	practices
O	1352	1359	overdue
O	1360	1363	for
O	1364	1374	mammograms
O	1374	1375	,
O	1376	1388	intervention
O	1389	1397	patients
O	1398	1402	were
O	1403	1411	somewhat
O	1412	1419	younger
O	1419	1420	,
O	1421	1425	more
O	1426	1432	likely
O	1433	1435	to
O	1436	1438	be
B-ethinicity	1439	1442	non
I-ethinicity	1442	1443	-
I-ethinicity	1443	1451	Hispanic
I-ethinicity	1452	1457	white
O	1457	1458	,
O	1459	1462	and
O	1463	1467	have
O	1468	1474	health
O	1475	1484	insurance
O	1484	1485	.

O	1486	1490	Most
O	1491	1503	intervention
O	1504	1513	providers
O	1514	1518	used
O	1519	1522	the
O	1523	1529	system
O	1530	1531	(
O	1531	1533	65
O	1534	1536	of
O	1537	1539	70
O	1540	1549	providers
O	1549	1550	,
O	1551	1553	92
O	1553	1554	.
O	1554	1555	9
O	1555	1556	%
O	1556	1557	)
O	1557	1558	.

B-outcome	1559	1565	Action
I-outcome	1566	1569	was
I-outcome	1570	1575	taken
O	1576	1579	for
B-iv-bin-abs	1580	1581	2
I-iv-bin-abs	1581	1582	,
I-iv-bin-abs	1582	1585	652
O	1586	1587	(
B-iv-bin-percent	1587	1589	86
I-iv-bin-percent	1589	1590	.
I-iv-bin-percent	1590	1591	8
I-iv-bin-percent	1591	1592	%
O	1592	1593	)
O	1594	1606	intervention
O	1607	1615	patients
O	1616	1617	[
O	1617	1618	2
O	1618	1619	,
O	1619	1622	274
O	1623	1624	(
O	1624	1626	74
O	1626	1627	.
O	1627	1628	5
O	1628	1629	%
O	1629	1630	)
O	1631	1640	contacted
O	1641	1644	and
O	1645	1648	378
O	1649	1650	(
O	1650	1652	12
O	1652	1653	.
O	1653	1654	4
O	1654	1655	%
O	1655	1656	)
O	1657	1665	deferred
O	1665	1666	]
O	1666	1667	.

B-outcome	1668	1673	After
I-outcome	1674	1675	1
I-outcome	1676	1680	year
I-outcome	1680	1681	,
I-outcome	1682	1693	mammography
I-outcome	1694	1699	rates
O	1700	1704	were
O	1705	1718	significantly
O	1719	1725	higher
O	1726	1728	in
O	1729	1732	the
O	1733	1745	intervention
O	1746	1749	arm
O	1750	1751	(
B-iv-bin-percent	1751	1753	31
I-iv-bin-percent	1753	1754	.
I-iv-bin-percent	1754	1755	4
I-iv-bin-percent	1755	1756	%
O	1757	1759	vs
B-cv-bin-percent	1760	1762	23
I-cv-bin-percent	1762	1763	.
I-cv-bin-percent	1763	1764	3
I-cv-bin-percent	1764	1765	%
O	1766	1768	in
O	1769	1776	control
O	1777	1780	arm
O	1780	1781	,
O	1782	1783	p
O	1784	1785	<
O	1786	1787	0
O	1787	1788	.
O	1788	1791	001
O	1792	1797	after
O	1798	1808	adjustment
O	1809	1812	for
O	1813	1821	baseline
O	1822	1833	differences
O	1833	1834	;
O	1835	1836	8
O	1836	1837	.
O	1837	1838	1
O	1838	1839	%
O	1840	1848	absolute
O	1849	1859	difference
O	1859	1860	,
O	1861	1863	95
O	1863	1864	%
O	1865	1867	CI
O	1868	1869	5
O	1869	1870	.
O	1870	1871	1
O	1871	1872	-
O	1872	1874	11
O	1874	1875	.
O	1875	1876	2
O	1876	1877	%
O	1877	1878	)
O	1878	1879	.

O	1880	1883	All
O	1884	1895	demographic
O	1896	1905	subgroups
O	1906	1915	benefited
O	1916	1920	from
O	1921	1924	the
O	1925	1937	intervention
O	1937	1938	.

O	1939	1951	Intervention
O	1952	1960	patients
O	1961	1970	completed
O	1971	1980	screening
O	1981	1987	sooner
O	1988	1992	than
O	1993	2000	control
O	2001	2009	patients
O	2010	2011	(
O	2011	2012	p
O	2013	2014	<
O	2015	2016	0
O	2016	2017	.
O	2017	2020	001
O	2020	2021	)
O	2021	2022	.

O	2023	2024	A
O	2025	2030	novel
O	2031	2041	population
O	2041	2042	-
O	2042	2047	based
O	2048	2059	informatics
O	2060	2066	system
O	2067	2078	functioning
O	2079	2081	as
O	2082	2086	part
O	2087	2089	of
O	2090	2091	a
O	2092	2095	non
O	2095	2096	-
O	2096	2101	visit
O	2101	2102	-
O	2102	2107	based
O	2108	2112	care
O	2113	2118	model
O	2119	2128	increased
O	2129	2140	mammography
O	2141	2150	screening
O	2151	2156	rates
O	2157	2159	in
O	2160	2172	intervention
O	2173	2182	practices
O	2182	2183	.

O	2184	2198	ClinicalTrials
O	2198	2199	.
O	2200	2203	gov
O	2203	2204	;
O	2205	2216	NCT00462891
O	2216	2217	.
